Framingham Genomics Medicine to Disband after Denial of Heart Data | GenomeWeb

NEW YORK, Dec 29 – Framingham Genomics Medicine, which planned to assemble, analyze, and sell data from the 52 year-old Framingham Heart Study, will disband after Boston University and the National Heart Lung and Blood Institute denied it access to the data, the university said Friday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.